Is Gyre Therapeutics, Inc. (GYRE) a Buy, Sell, or Hold?
NASDAQ : GYRE
Gyre Therapeutics, Inc. — Competitors
$6.72 USD
$0.05 (0.75%)
- Volume
- 51.54K
- Average Volume
- 82.66K
- Market Capitalization
- $614.15M
- P/E Ratio
- -33.79
- Dividend Yield
- 0.00%
- Price Target
- $17.00
- Year High
- $9.42
- Year Low
- $5.44
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.26
GYRE vs. The Competition
| Properties | GYRE | ATXS | AVBP | AVXL |
|---|---|---|---|---|
| Market Cap | $614.15M | $718.13M | $1.44B | $314.16M |
| Shares Outstanding | $91.39M | $57.08M | $46.57M | $92.67M |
| P/E Ratio | -33.79 | -7.4 | -8.78 | -8.66 |
| EPS | -0.17 | -1.7 | -3.22 | -0.37 |
| Day Low | 6.66 | 12.58 | 30.37 | 3.285 |
| Day High | 6.76 | 12.58 | 31.13 | 3.44 |
| Year Low | 5.44 | 3.555 | 16.1 | 2.255 |
| Year High | 9.42 | 13.29 | 35.83 | 11.7 |
| Average Price 50 | 6.2082 | 12.7446 | 31.6117 | 2.6544 |
| Average Price 200 | 7.2534 | 8.31845 | 25.59048 | 3.90873 |
| Volume | 51541 | 3.06M | 464.49K | 627.94K |
| Average Volume | - | - | - | - |